Read more

December 16, 2020
1 min watch
Save

Optimizing treatment for localized RCC, metastatic disease

Healio spoke with Elizabeth Plimack, MD, chief of the division of genitourinary medical oncology at Fox Chase Cancer Center, on new developments in treatment for patients with renal cell carcinoma.

Specifically, researchers are assessing adjuvant therapies for patients with localized RCC and how to optimize therapy for previously treated patients with metastatic disease, she said.

Click here to watch the next video in the series on exciting areas of research in RCC.